| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-04-27 22:37:25 UTC |
|---|
| Updated at | 2022-04-27 22:37:25 UTC |
|---|
| NP-MRD ID | NP0051231 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | Hydroquinidine |
|---|
| Description | Hydroquinidine, also known as LCN 834 or lentoquine, belongs to the class of organic compounds known as cinchona alkaloids. These are alkaloids structurally characterized by the presence of the cinchonan skeleton, which consists of a quinoline linked to an azabicyclo[2.2.2]Octane moiety. Hydroquinidine is found in Aspidosperma marcgravianum, Cinchona officinalis and Remijia pedunculata. Hydroquinidine was first documented in 2019 (PMID: 31441080). Based on a literature review a small amount of articles have been published on hydroquinidine (PMID: 35467248) (PMID: 33324992) (PMID: 32025785) (PMID: 31930659). |
|---|
| Structure | CC[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)C1=CC=NC2=CC=C(OC)C=C12 InChI=1S/C20H26N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h4-6,8,11,13-14,19-20,23H,3,7,9-10,12H2,1-2H3/t13-,14-,19+,20-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| LCN 834 | MeSH | | LCN-834 | MeSH | | Lentoquine | MeSH | | Sérécor | MeSH | | Dihydroquinidine | MeSH | | Dihydroquinine | MeSH | | Hydroquinidine dihydrochloride, (1beta,4beta,3S)-(+-)-isomer | MeSH | | Hydroquinidine dihydrochloride, (3alpha,9S)-(+-)-isomer | MeSH | | Hydroquinidine hydrochloride | MeSH | | Hydroquinidine monosulfate | MeSH | | Hydroquinidine monosulfate, (1beta,3alpha,4beta,8alpha,9R)-isomer | MeSH | | Hydroquinidine monosulfate, (1beta,3alpha,4beta,9S)-isomer | MeSH | | Hydroquinidine sulfate | MeSH | | Hydroquinidine sulfate, (9S)-isomer | MeSH | | Hydroquinidine, (+-)-isomer | MeSH | | Hydroquinidine, (1beta, 3alpha,4beta,8alpha,9R)-isomer | MeSH | | Hydroquinidine, (1beta,3alpha,4beta,9S)-isomer | MeSH | | Hydroquinidine, (1beta,4beta,9S)-(+-)-isomer | MeSH | | Hydroquinidine, (3alpha,9S)-(+-)-isomer | MeSH | | Hydroquinidine, (8alpha,9R)-isomer | MeSH | | Hydroquinidine, (8alpha,9S)-isomer | MeSH | | Hydroquinidine, (9R)-isomer | MeSH | | Hydroquinidine, (9S)-(+-)-isomer | MeSH | | Hydroquinine | MeSH |
|
|---|
| Chemical Formula | C20H26N2O2 |
|---|
| Average Mass | 326.4400 Da |
|---|
| Monoisotopic Mass | 326.19943 Da |
|---|
| IUPAC Name | (S)-[(2R,4S,5R)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl](6-methoxyquinolin-4-yl)methanol |
|---|
| Traditional Name | (S)-[(2R,4S,5R)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl](6-methoxyquinolin-4-yl)methanol |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)C1=CC=NC2=CC=C(OC)C=C12 |
|---|
| InChI Identifier | InChI=1S/C20H26N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h4-6,8,11,13-14,19-20,23H,3,7,9-10,12H2,1-2H3/t13-,14-,19+,20-/m0/s1 |
|---|
| InChI Key | LJOQGZACKSYWCH-LHHVKLHASA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as cinchona alkaloids. These are alkaloids structurally characterized by the presence of the cinchonan skeleton, which consists of a quinoline linked to an azabicyclo[2.2.2]Octane moiety. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Alkaloids and derivatives |
|---|
| Class | Cinchona alkaloids |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Cinchona alkaloids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Cinchonan-skeleton
- 4-quinolinemethanol
- Quinoline
- Anisole
- Quinuclidine
- Alkyl aryl ether
- Aralkylamine
- Piperidine
- Pyridine
- Benzenoid
- Heteroaromatic compound
- 1,2-aminoalcohol
- Tertiary aliphatic amine
- Tertiary amine
- Secondary alcohol
- Ether
- Azacycle
- Organoheterocyclic compound
- Organooxygen compound
- Organonitrogen compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Organopnictogen compound
- Amine
- Alcohol
- Organic oxygen compound
- Aromatic alcohol
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Katis G, Wiles B, Saba MM: Short-coupled ventricular ectopics leading to cardiac arrest in a young woman. Egypt Heart J. 2022 Apr 25;74(1):32. doi: 10.1186/s43044-022-00272-y. [PubMed:35467248 ]
- Steinfurt J, Bezzina CR, Biermann J, Staudacher D, Marschall C, Trolese L, Faber TS, Duerschmied D, Zehender M, Bode C, Wilde AAM, Odening KE, Lodder EM: Two siblings with early repolarization syndrome: clinical and genetic characterization by whole-exome sequencing. Europace. 2021 May 21;23(5):775-780. doi: 10.1093/europace/euaa357. [PubMed:33324992 ]
- Horn N, Rub N, Wolpert C: [Long and short QT syndromes : Emergency treatment and secondary prophylaxis]. Herzschrittmacherther Elektrophysiol. 2020 Mar;31(1):48-54. doi: 10.1007/s00399-020-00666-y. Epub 2020 Feb 5. [PubMed:32025785 ]
- Doisne N, Waldmann V, Redheuil A, Waintraub X, Fressart V, Ader F, Fosse L, Hidden-Lucet F, Gandjbakhch E, Neyroud N: A novel gain-of-function mutation in SCN5A responsible for multifocal ectopic Purkinje-related premature contractions. Hum Mutat. 2020 Apr;41(4):850-859. doi: 10.1002/humu.23981. Epub 2020 Jan 25. [PubMed:31930659 ]
- El-Battrawy I, Roterberg G, Liebe V, Ansari U, Lang S, Zhou X, Borggrefe M, Akin I: Implantable cardioverter-defibrillator in Brugada syndrome: Long-term follow-up. Clin Cardiol. 2019 Oct;42(10):958-965. doi: 10.1002/clc.23247. Epub 2019 Aug 22. [PubMed:31441080 ]
|
|---|